RAP media thread., page-1724

Of course. I am not talking of revenue with Ilara, but acceptance or proof of outcome, ie successful diagnosis of respiratory disease. Telehealth is naked when it comes to respiratory disease. But ResApp gives telehealth a powerful tool which, if marketed well by providers, will provide strong revenue for all partners and successful outcomes for patients.

It takes just one domino to fall. Then all competitors will clamber for our AI. Because otherwise they will be naked.